生物及临床检测用纳米抗体/Nanobodies for Biotechnology and Clinical Diagnostics - 永利官网

永利官网,永利官网ylg客户端

新闻动态 | 党群建设 | 联系我们
永利官网 / / 生物及临床检测用纳米抗体/Nanobodies for Biotechnology and Clinical Diagnostics
生物及临床检测用纳米抗体/Nanobodies for Biotechnology and Clinical Diagnostics

       纳米抗体是小型化的抗体,可在科研中标记纯化目标蛋白、临床诊断中进行免疫诊断。本项目将构建纳米抗体开发平台,实现成果批量转化。     

       ?体积小,亲水,耐热耐酸碱,性能稳定易保存 

       ?结构简单,易生物合成,生产成本低

       ?化学性质灵活,与抗原结合力强,检测灵敏度高

       A nanobody is a single domain antibody; it can be used to label or purify target proteins in biomedical research, and in immunohistochemistry during clinical diagnosis. The market size for breast cancer diagnosis is up to 200 million CNY. This project will lead to a nanobody R&D platform and realize its commercialization in batches.

       ?Light-weight, hydrophilic, thermal/pH stable, long shelf life with stable performance

       ?Simple structure, easy to synthesize, low cost

       ?Flexible chemical characteristics, strong binding affinity to antigens, and high sensitivity in assays